IBIO-610 with semaglutide cut lean mass loss to 6% in a primate study
In obese primates, lean mass made up 6% of weight lost on the combo versus 22% on semaglutide alone. Human trials are expected in the first half of 2027.
Recap by typeshit. Full story at Longevity.Technology.